Tubular adenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
17
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Chlamydia trachomatis infection
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
36
|
1
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Colonic Polyps
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Anatomical Abnormality
|
69
|
8
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Childhood Acute Monocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Adult Acute Monocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Osteoporotic Fractures
|
group |
Wounds and Injuries
|
Disease or Syndrome
|
108
|
40
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
M5b Acute differentiated monocytic leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
122
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Adult Solid Neoplasm
|
group |
|
Neoplastic Process
|
163
|
3
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Childhood Solid Neoplasm
|
phenotype |
|
Neoplastic Process
|
169
|
3
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Hyperplastic Polyp
|
disease |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
204
|
22
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Primary Myelofibrosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
282
|
29
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Benign Neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
371
|
7
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
413
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
418
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Sleep Apnea, Obstructive
|
disease |
Respiratory Tract Diseases; Nervous System Diseases
|
Disease or Syndrome
|
480
|
105
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Acute monocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
633
|
22
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Acute leukemia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
639
|
50
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Osteopenia
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
845
|
61
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Leukemogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
996
|
25
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2001 |
Osteoporosis
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
1098
|
182
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |